MedPath

MINOCYCLINE HYDROCHLORIDE

MINOCYCLINE HYDROCHLORIDE TABLETS, USP Rx only

Approved
Approval ID

3539f84e-b489-4914-96c1-ac3731032971

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 18, 2022

Manufacturers
FDA

Torrent Pharmaceuticals Limited

DUNS: 650175722

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MINOCYCLINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code13668-485
Application NumberANDA065156
Product Classification
M
Marketing Category
C73584
G
Generic Name
MINOCYCLINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateMarch 22, 2022
FDA Product Classification

INGREDIENTS (11)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CROSPOVIDONE (15 MPA.S AT 5%)Inactive
Code: 68401960MK
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOL 6000Inactive
Code: 30IQX730WE
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
MINOCYCLINE HYDROCHLORIDEActive
Quantity: 50 mg in 1 1
Code: 0020414E5U
Classification: ACTIM

MINOCYCLINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code13668-486
Application NumberANDA065156
Product Classification
M
Marketing Category
C73584
G
Generic Name
MINOCYCLINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateMarch 22, 2022
FDA Product Classification

INGREDIENTS (11)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CROSPOVIDONE (15 MPA.S AT 5%)Inactive
Code: 68401960MK
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOL 6000Inactive
Code: 30IQX730WE
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
MINOCYCLINE HYDROCHLORIDEActive
Quantity: 75 mg in 1 1
Code: 0020414E5U
Classification: ACTIM
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

MINOCYCLINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code13668-487
Application NumberANDA065156
Product Classification
M
Marketing Category
C73584
G
Generic Name
MINOCYCLINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateMarch 22, 2022
FDA Product Classification

INGREDIENTS (11)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CROSPOVIDONE (15 MPA.S AT 5%)Inactive
Code: 68401960MK
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
POLYETHYLENE GLYCOL 6000Inactive
Code: 30IQX730WE
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
MINOCYCLINE HYDROCHLORIDEActive
Quantity: 100 mg in 1 1
Code: 0020414E5U
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MINOCYCLINE HYDROCHLORIDE - FDA Drug Approval Details